ATE339447T1 - Hochaffine antagonisten der elr-cxc chemokine - Google Patents

Hochaffine antagonisten der elr-cxc chemokine

Info

Publication number
ATE339447T1
ATE339447T1 AT02703428T AT02703428T ATE339447T1 AT E339447 T1 ATE339447 T1 AT E339447T1 AT 02703428 T AT02703428 T AT 02703428T AT 02703428 T AT02703428 T AT 02703428T AT E339447 T1 ATE339447 T1 AT E339447T1
Authority
AT
Austria
Prior art keywords
antagonists
elr
afffine
cxc chemokines
cxc
Prior art date
Application number
AT02703428T
Other languages
English (en)
Inventor
John R Gordon
Fang Li
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Application granted granted Critical
Publication of ATE339447T1 publication Critical patent/ATE339447T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Power Steering Mechanism (AREA)
AT02703428T 2001-03-01 2002-03-01 Hochaffine antagonisten der elr-cxc chemokine ATE339447T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27318101P 2001-03-01 2001-03-01

Publications (1)

Publication Number Publication Date
ATE339447T1 true ATE339447T1 (de) 2006-10-15

Family

ID=23042842

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02703428T ATE339447T1 (de) 2001-03-01 2002-03-01 Hochaffine antagonisten der elr-cxc chemokine

Country Status (11)

Country Link
US (3) US7201895B2 (de)
EP (1) EP1363944B1 (de)
JP (1) JP2004534521A (de)
AT (1) ATE339447T1 (de)
AU (1) AU2002237136B2 (de)
CA (1) CA2439452C (de)
DE (1) DE60214676T2 (de)
DK (1) DK1363944T3 (de)
ES (1) ES2274957T3 (de)
HK (1) HK1062689A1 (de)
WO (1) WO2002070565A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1363944T3 (da) 2001-03-01 2007-01-08 Univ Saskatchewan Höjaffinitetsantagonister for ELR-CXC-kemokiner
ATE530650T1 (de) * 2006-05-16 2011-11-15 Univ Saskatchewan Hochaffine antagonisten von elr-cxc-chemokinen
WO2009100530A1 (en) * 2008-02-12 2009-08-20 University Of Saskatchewan Uses of modified elr-cxc chemokine g31p
US8299019B2 (en) * 2008-02-12 2012-10-30 Gordon John R Uses of modified ELR-CXC chemokine G31P to treat cancer
KR101247641B1 (ko) * 2010-10-22 2013-03-29 성균관대학교산학협력단 Ｃｘｃｒ２에 결합하는 펩타이드 리간드를 포함하는 감염성 및 염증성 질환 치료용 조성물
KR20140038379A (ko) 2011-03-03 2014-03-28 데노바메드 인코퍼레이티드 항균성/보조 화합물 및 방법
DK3441474T3 (da) 2013-06-18 2020-08-17 Univ New York Farmaceutiske sammensætninger indeholdende et muteret leukocidin e
US10075024B2 (en) 2015-05-22 2018-09-11 La-Z-Boy Incorporated Apparatus and method for wireless power transfer in furniture
EP3551046B1 (de) 2016-12-07 2023-07-19 Biora Therapeutics, Inc. Verfahren, vorrichtungen und systeme zur detektion des magen-darm-trakts
CA3045310A1 (en) 2016-12-14 2018-06-21 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
CN109022599A (zh) * 2018-10-08 2018-12-18 河南科技学院 检测奶牛CCL28基因单核苷酸多态性的试剂盒及RFLP方法及相关SNPs
KR20210095165A (ko) 2018-11-19 2021-07-30 프로제너티, 인크. 바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스
CN115666704A (zh) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69226649D1 (de) * 1991-12-04 1998-09-17 Biomedical Research Centre Ltd Analoge des menschlichen Interleukin-8.
AU6283996A (en) * 1995-06-20 1997-01-22 Chiron Corporation Polypeptides with interleukin-8 receptor binding
DK1363944T3 (da) 2001-03-01 2007-01-08 Univ Saskatchewan Höjaffinitetsantagonister for ELR-CXC-kemokiner

Also Published As

Publication number Publication date
CA2439452A1 (en) 2002-09-12
US20070021593A1 (en) 2007-01-25
WO2002070565A2 (en) 2002-09-12
CA2439452C (en) 2012-05-15
EP1363944B1 (de) 2006-09-13
US20030077705A1 (en) 2003-04-24
US20090118469A1 (en) 2009-05-07
US7741434B2 (en) 2010-06-22
WO2002070565A3 (en) 2002-12-19
DE60214676D1 (de) 2006-10-26
US7201895B2 (en) 2007-04-10
WO2002070565A9 (en) 2002-10-31
ES2274957T3 (es) 2007-06-01
AU2002237136B2 (en) 2007-11-01
JP2004534521A (ja) 2004-11-18
DK1363944T3 (da) 2007-01-08
HK1062689A1 (en) 2004-11-19
EP1363944A2 (de) 2003-11-26
DE60214676T2 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
ATE339447T1 (de) Hochaffine antagonisten der elr-cxc chemokine
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
TNSN07196A1 (en) Potentiators of glutamate receptors
GB0115862D0 (en) Compounds
SG149693A1 (en) Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
DK1773885T3 (da) Humaniserede anti-c-met-antagonister
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
MX337423B (es) Antagonistas anti-beta7 humanizados y usos para los mismos.
EA200300593A1 (ru) Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора
DE60125429D1 (de) Zolpidem hemitartrat solvat
DE60230722D1 (de) Il-8-rezeptor-antagonisten
ATE312096T1 (de) Neue verbindungen
EA200200933A1 (ru) Антагонисты рецептора il-8
ATE390482T1 (de) Interleukin-1 hy2. mittel und verfahren
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
UA87122C2 (ru) Агонисты рецепторов глюкагонподобного пептида-1, их применение и способ получения
DE60218183D1 (de) Methoden für die konstruktion und screening von chemokine varianten
SG158098A1 (en) Toll like receptor 3 antagonists, methods and uses
MXPA05011762A (es) Antagonistas de receptor de glutamato como neuroprotectores.
CY1105785T1 (el) Μεθοδοι παρασκευης της 2-(7-χλωρο-1,8-ναφθυριδιν-2-υλ)-3-(5-μεθυλ-2-οξο-εξυλ)-1-ισοϊνδολινονης
SE0303418D0 (sv) New use 1
MXPA04001166A (es) Usos de citocina de mamifero; reactivos relacionados.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties